Stefano Pucci
Civitanova Marche, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study.
Journal: Allergy
Published: February 24, 2026
Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network.
Journal: Frontiers in immunology
Published: January 17, 2026
The Impact of COVID-19 on Patients With Bradykinin-Mediated Angioedema in the ITACA Cohort.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: December 10, 2024
Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.
Journal: Clinical and molecular allergy : CMA
Published: August 22, 2024
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.
Journal: Clinical and molecular allergy : CMA
Published: February 24, 2022
Maintenance venom immunotherapy administered at 12-week intervals in patients with high basal tryptase.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: September 28, 2021
Management of patients with severe asthma: results from a survey among allergists and clinical immunologists of the Central Italy Inter-Regional Section of SIAAIC.
Journal: Clinical and molecular allergy : CMA
Published: August 31, 2021
Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series.
Journal: Journal of asthma and allergy
Published: December 04, 2020
ACEIs and beta blockers as a risk factor for severe reactions to Hymenoptera venom, facts or fictions?
Journal: The Journal of allergy and clinical immunology
Published: July 21, 2020
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: May 22, 2020
Last Updated: 09/26/2026